gip glp 1 glucagon agonists GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica Gut hormone polyagonists for the
Description
How much GLP-1 do you take
Are you a candidate?
Here's what experts think.
We also describe the development of incretin-based pharmacotherapy, starting with exendin- 4 and ending with the identification of multi-incretin hormone receptor agonists, which appear to be the next major step in the fight against T2DM and obesity
It is HERE
